Tekcapital shares jump after MicroSalt listed on Amazon UK platform

Tekcapital shares jumped on Tuesday after the technology-focused investment company announced MicroSalt has introduced its low-sodium shakers on the Amazon UK platform.

Tekcapital shares were 5.8% higher at the time of writing.

In addition, and in support of its UK expansion, MicroSalt has forged a strategic local distribution partnership with Reliable Express in Southampton.

The agreement provides the storage and distribution of MicroSalt’s bulk-packed products, catering to the growing B2B market demand within the food distribution and manufacturing sectors in both the UK and EU markets.

MicroSalt is supplying some of the world’s largest snack foods businesses with large quantities of low-sodium salt requiring substantial storage and distribution capabilities.

In their admission document released last year, MicroSalt described demand from a large multinational for their Latin American businesses in the form of a 9.5mt order. Today’s announcement suggests MicroSalt is gearing up for large orders from European businesses.

“Inclusion of our low sodium solutions on the Amazon shopping platform is key to our efforts to make MicroSalt readily available to meet the demand of our B2C customers,” said Rick Guiney, CEO of MicroSalt®.

“Additionally, our partnership with Reliable Express in the UK is a vital piece of our growing distribution network as it will allow us to reliably and efficiently service food manufacturing channels in both the UK and EU. Excess sodium consumption is one of the leading contributors to hypertension and heart disease. Now MicroSalt will be available to help consumers in the UK and Europe enjoy great tasting, healthy products with less sodium.”

FTSE 100 slips with commodities in focus

The FTSE 100 was weaker on Monday as miners and oil majors dragged on the index after Saudi Arabia cut its oil prices and enthusiasm around interest rate cuts began to ebb.

Global equities had a stellar end to 2023 on hopes central banks would start to cut rates early in the new year. However, since then, economic data points and central bank comments suggest the first cuts won’t come as soon as some market participants hope.

Indeed, market pricing of rate cuts has reversed slightly since the turn of the year, which continued in equities and fixed income on Monday. London’s leading index had been sharply lower earlier in the session, but dip buyers stepped in to provide support as trade progressed.

The FTSE 100 was down 0.15% at the time of writing.

“The FTSE 100 dipped on Monday as weak commodity prices hit the big resources stocks which populate the index,” said AJ Bell investment director Russ Mould.

“In general, the momentum which stocks built up in the latter part of 2023 seems to have been lost for now as some of the excitement over interest rates has dissipated and doubt has crept in about a soft landing for the economy.

“US inflation figures scheduled for Thursday could either help get markets out of their mild New Year funk or put shares under renewed pressure, so this release will be closely monitored. Disruption to shipping routes in the Red Sea are hinting at renewed inflationary pressures coming down the pipe.”

FTSE 100 movers

The FTSE 100’s commodity companies were the main detractors of the index’s performance with Glencore, BP, Shell and Anglo American down between 1.3% – 2.4%.

However, after last week’s shock profit warning, JD Sports was the top faller as the sell-off continued. JD Sports shares are now worth 29.9% less than they were at the end of 2023 and are by far the FTSE 100’s worst performer so far in 2024.

Melrose was the top gainer amid fluctuations in the aerospace caused by Boeing’s malfunction over the weekend. Those in Boeing’s supply chain are suffering while competitor supply chains are benefiting.

Oil sinks on increased OPEC output and Saudi Arabia price cuts

On Monday, both WTI and Brent Crude dropped by almost 3% on the news of significant price reductions from leading exporter Saudi Arabia and an increase in the Organisation of the Petroleum Exporting Countries’ (OPEC) output.

WTI Crude was down by 2.91%, while Brent Crude was down by almost 2.70% at the time of writing on Monday.

Saudi Arabia has slashed its crude selling prices to Asian customers, marking the most significant price cut in 13 months.

Saudi Aramco, the country’s oil giant, reduced its flagship Arab Light price by $2 per barrel.

Counteracting the rise in prices driven by geopolitical tensions, a recent Reuters survey revealed that output from OPEC increased by 70,000 bpd in December, reaching 27.88 million bpd.

Antony Blinken, the U.S. Secretary of State currently in the Middle East, further warned that, without a coordinated peace initiative, the Gaza conflict has the potential to escalate throughout the region.

Additionally, in the U.K., “the current Conservative government, whose tenure effectively dates back to 2010 and covers a flurry of five prime ministers, could be seen as having taken an increasingly interventionist approach to the economy, given such initiatives as sugar taxes, Help to Buy, energy price caps, and windfall taxes on North Sea oil producers,” said AJ Bell investment director Russ Mould.

Shell shares dip after signalling impairment costs

Shell shares were lower on Monday after the oil gaint signaled up to $4.5bn in impairment costs due to the write down refining assets and lower energy prices weighs on profit.

The oil major released its earnings teaser amid falling oil prices on Monday after Saudi Arabia said it was cutting prices.

Shell shares were down 1.8% at the time of writing.

“The usual teaser for Shell’s quarterly results did little to enthuse investors as Saudi Arabia’s decision to cut crude prices dampened sentiment towards the sector,” said AJ Bell’s Russ Mould.

“If it wasn’t for the threat of disruption to supplies thanks to tensions in the Middle East, one might have expected crude prices to come under sustained pressure as inventories and production build and signs of demand weakness emerge.

“At least Shell can lean on its big integrated gas arm. Though news its performance improved in the fourth quarter – when many of the world’s big consumers of natural gas are facing seasonally cold temperatures – hardly feels like a big revelation.”

Integrated gas was a bright spot in an otherwise run of the mill update that will do little to encourgage investors, especially with energy prices languishing despite efforts by OPEC+ to support oil prices.

“A weak performance for its chemicals division is compounded by the big writedown associated with a Singapore refining hub it is looking to sell,” Russ Mould said.

“Shell has been a beneficiary of higher commodity prices over the approximate two years which have followed Russia’s invasion of Ukraine. The company needs to show it can deliver when market conditions aren’t so helpful.

Boeing shares crash on the news of an FAA grounding order

2

On Monday, Boeing shares crashed to 8.5% both in the US pre-market on the news of a temporary grounding order issued by the U.S. Federal Aviation Administration (FAA) for a number of Boeing 737 MAX 9 jets.

On Friday, a Boeing 737 Max 9 jet experienced an emergency door plug detachment shortly after takeoff from Portland, Oregon, bound for Ontario, California. The aircraft returned and safely landed after the incident. 

While some passengers received treatment for minor injuries, no fatalities were reported. In response, the Federal Aviation Administration (FAA) issued a temporary grounding order for approximately 171 Boeing jets on Saturday. 

The FAA emphasized that the planes would remain grounded until they are deemed safe to resume operations.

“Boeing’s reputation has been shattered after the incident last Friday involving one of its 737 Max planes flown by Alaska Airlines. It is the latest in a string of problems for the company, which include the grounding of 737 Max plans in 2019 after two crashes and subsequent delivery delays and production issues,”  said AJ Bell Investment director Russ Mould.

“Safety is of paramount importance in the aviation sector and airlines using 737 Max planes will be thinking long and hard about their future aircraft requirements and how Boeing might play a smaller role, or none at all. That might explain why Airbus shares jumped on Monday as investors are betting it could take even more market share from Boeing,” Mould added.

Airbus shares were up 2.32% at the time of writing on Monday.

“There is no room for error building planes and cutting corners in the production stage could have catastrophic consequences. There are naturally questions being asked about the quality checks and whether Boeing is trying to do too much too fast,” said Russ Mould.

“Boeing’s management will be under considerable pressure from the regulators and customers to explain what’s going on, which means considerable headwinds ahead for the business. It’s no wonder investors have raced to sell the shares as the risks to the investment case have just shot up,” Mould added.

AIM movers: Poor fourth quarter for CMO and Oriole Resources receives earn-in payment

0

Oriole Resources (LON: ORR) has confirmed receipt of the payment of $450,000 related to the earn-in agreement with BCM International for the Bibemi gold exploration project in Cameroon. BCM will spend $4m on exploration to earn 50% of the project. Drilling should resume in the first quarter. The share price is 17.1% higher at 0.24p.

Data analysis software and services provider Celebrus Technologies (LON: CLBS), formerly D4T4, won four contracts in the fourth quarter. Two new contracts are for three years and are in the retail and healthcare sectors. The other two are extensions of existing contracts with banks. These contracts help to underpin the expected improvement in pre-tax profit from £3.7m to £5.3m in the year to March 2024. The share price increased 9.77% to 236p.

Verici Dx (LON: VRCI) says that the Medicare national payment rate for post-kidney transplant test Tutivia and pre-kidney transplant test Clarava are effective from 1 January 2024. The rate for both of them is $2,650. The company’s testing laboratory has been accredited by the College of American Pathology. The share price rose 5.77% to 11p.

Mrs Nashida Islam-Bonnier has cut her stake in podcast platform Audioboom (LON: BOOM) from 3.7% to below 3%. The share price moved up 5.74% to 322.5p.

FALLERS

Online builders’ merchant CMO Group (LON: CMO) had a tough fourth quarter. Online traffic rates declined, but conversion rates improved. Overall orders were flat. Home improvement and DIY spending is declining. The overall repair, maintenance and improvement sector is still relatively strong, but it weakened in the second half of 2023. Market share has grown, and costs have been cut. Liberum has increased its 2023 pre-tax loss forecast from £800,000 to £1.2m and forecasts a 2024 loss. The share price fell 12.7% to 24p.

N4 Pharma (LON: N4P) says that its Nuvec silica nanoparticle delivery system for vaccines improved efficacy when mixed with AAV8 vector and used to traduce human-like liver cells. It was 2.5 times better than AAV8 on its own. This means that lower does could be used. Even so, the share price dipped 7.69% to 1.2p although that was from a recent high.

Morocco-based potash project developer Emmerson (LON: EML) is still waiting for government approval of its Environmental and Social Impact Study for the Khemisset potash mine. This requires a ministerial meeting. Debt financing has been extended for 12 months. The share priced declined 6.9% to 1.35p.

On Friday afternoon, Sri Lanka mineral sands project developer Capital Metals (LON: CMET) says that offtake discussions with LB Group are now non-exclusive. There has been additional interest in the Eastern Minerals project. The share price fell on Friday, and it has dropped a further 5.97% to 3.15p.

Consultancy Elixirr International (LON: ELIX) confirmed 2023 results are in line with expectations and it will pay two dividends each year. Pre-tax profit is expected to improve from £19.3m to £23.9m. The shares will go ex-dividend for the 5.3p/share interim on 19 January. Profit-taking knocked 5.65% off the share price leaving it at 585p.  

Marks & Spencer festive trading update preview

There is no doubt that Marks & Spencer had a tremendous year in 2023, and investors will hope for more of the same in the coming year.
Marks & Spencer shares are up 107% over the past year, and this week's trading update is crucial for the continuation of the rally.
Both in terms of profitability and returns for shareholders, M&S made strides forward in 2023. The festive trading period can potentially top off one of the best trading periods for Marks and Spencer in years.
M&S’s food business has long been the main event. Even before the pandemic, growth in the area was support...

Aquis weekly movers: Coinsilium share buying

Coinsilium (LON: COIN) was the biggest riser on the week with a 55.3% improvement to 2.95p. This is the highest the share price has been since August 2022. The increased trading levels at the end of December continued into early January. The vast majority of the trades were buys with limited selling.

Professor Trevor Jones bought 150,000 shares in EDX Medical Group (LON: EDX) at 6.25p each and 139,074 shares at 7.35p each. These are his first share purchases, and he owns 0.096% of EDX Medical. The share price rose 26.1% to 7.25p. This is the highest level since just after the flotation in June 2021

NFT Investments (LON: NFT) reported a 54% increase in NAV to £43.8m at the end of September. Crypto assets rose by 67% and there are plans to liquidate these holdings after April. There will then be a tender offer to shareholders. NAV is 4.67p/share. Even so, the share price edged up 1.89% to 2.7p, due to concerns about the liquidity and volatility of the crypto holdings.

FALLERS

Founder Paul Ryan reduced his stake in Pharma C Investments (LON: PCIL) from 8.52% to 3.9%, while James Formolli took a 8.05% shareholding. The share price slumped 65.6% to 0.055p. The May 2021 placing price was 0.7p.

SHARE TIP: Is this Lightship showing the way as the shipping sector comes alight 

Just as the world’s shipping market is starting to suffer from the current turmoil in the Eastern Mediterranean waters around Israel, there is a Lightship clearly showing a preferred route. 
There are now very worrying signs of the significant and persistent disruption in the Red Sea, due to the Iranian-backed Houthi rebels attacking some 24 ships in an effort to close off the straits entering the Suez Canal. 
Some 12% of the world’s seaborne trade uses the canal for transit of cargoes. 
Last week the shipping giant, Maersk, declared that it was re-routing its shipments around t...

AIM weekly movers: Positive DNA news from Angle

4

Cancer diagnostics firm Angle (LON: AGL) has made two positive announcements during the week. There are breakthrough results from DNA molecular analysis of cancer patient blood samples, and this covers many types of cancer. This proves the effectiveness of the Parsortix system combined with DNA analysis. Angle believes that using CTC-DNA testing of living cancer cells alongside ctDNA (DNA fragments released from dead cancer cells into the blood) will improve the way cancer is treated. It may enable doctors to track the clonal evolution of a patient’s cancer. Earlier in the week, a $250,000 pilot study to assess breast cancer patients was secured. The share price jumped 121% to 26p.

An $11m preclinical milestone payment to C4X Discovery (LON: C4XD) has been triggered by the preclinical progress of C4XD’s NRF2 Activator programme. AstraZeneca is using the programme to develop an oral therapy for treating inflammatory and respiratory diseases. At the end of July 2023, C4XD had £4.22m in the bank after a £6m cash outflow from operating activities. The share price increased 98.3% to 17.85p.

Trading in Trellus Health (LON: TRLS) shares last Friday was at the second highest level in the past year. At one point the share price moved above 7p, but it ended up 69.2% up on the week at 5.5p. That is the highest price since October. Management is in talks with a large US national health plan which will make digital product Trellus Elevate, which helps people to manage inflammatory bowel disease, more widely available.

Shantonu Kumar Chundur has taken a 5.07% stake in i-nexus Global (LON: INX). The Coventry-based software company is loss making and it lost a major client in October. The share price recovered 51.1% to 3.4p, which is the highest level since early November.

FALLERS

Revolution Bars (LON: RBG) like-for-like sales were 9% ahead in December. However, most of that growth came from Revolucion de Cuba and Peach Pubs with Revolution barely growing even though the previous December’s train strikes meant that comparatives were weak. Eight bars have been closed. That leaves 58 bars and 22 pubs. Net debt is £18.3m. There will be another trading update on 24 January. The share price slumped 24.6% to 4.3p.

Plexus Holdings (LON: POS) shares fell 21.4% to 16.5p, after falling below 14p at one point. Plexus agreed an IP licence agreement with SLB, which replaces a previous surface production wellhead licence agreement with a subsidiary of SLB. For $5.2m in cash, SLB gets a licence in perpetuity to use POS-GRIP technology in specific markets. The 2023-24 revenues forecast has been upgraded to £14m and pre-tax profit raised by 467% to £1.7m. However, this is a one-off, so Plexus could fall back into loss next year. Plexus was the best AIM performer in 2023 and it is still the best performer since the end of 2022.

Landore Resources Ltd (LON: LND) has raised £600,000 at 2.4p/share. This will help to fund the early development of the BAM gold project in Northwestern Ontario. Results from last year’s infill core sampling work will be reported during the first quarter of 2024. There will be a drilling programme this year. The postponement of the TSX Venture Exchange listing and the related fundraising has led to cost savings including the stepping down of chief executive Claude Lemasson and non-exec Larry Strauss. Glenn Featherby becomes interim chief executive. The share price slipped 19% to 2.55p.

Mkango Resources (LON: MKA) has a 79.4% interest in Maginito, which has formed a 50/50 joint venture with CoTec Holdings. HyProMag USA will roll out Hydrogen Processing of Magnet Scrap recycling technology. Maiden revenues are expected in 2025-26. The share price declined 15.2% to 9.75p.